Useful links about Patent strategy and IP

Pharmaceutical patents are exclusive rights granted to inventors, pharmaceutical companies, or research organizations to protect their innovations in drug development. Patents are considered crucial assets within therapy development as they allow the inventor rights over an invention for typically 20 years post filing. These inventions could include information on drug formulation, dosage or efficacy, as well as information on the product properties of leads or pre-clinical candidates.

The Netherlands Patent Office (Octrooicentrum Nederland) is the patent granting authority for the Netherlands. It is part of the Netherlands Enterprise Agency.

As a researcher in academia or a research institute you can consult the the Knowlegde Transfer Office (KTO) of Technology Transfer Office (TTO) of your institute for advice on patent strategy and IP. KWF published an overview of TTOs on their website.

European